Tag Archives: GGG

Top 5 Medical Stocks To Watch Right Now

Investing in biotechs can be an exercise in frustration, as Lexicon Pharmaceuticals (NASDAQ:LXRX) so amply demonstrates. While I believe the company has continued to build a solid case that its dual SGLT-1/2 inhibitor sotagliflozin can and should be approved for use in Type 1 diabetes, the shares are down about 20% from the time of my last update. Although the data package on sotagliflozin is not perfect, I believe it shows acceptable safety and worthwhile efficacy for a patient group with virtually no medical treatment options beyond insulin.

InTandem2 Comes In Pretty Much As Expected

Before the open on December 21, Lexicon announced the results of its inTandem2 study – the second of three Phase III studies it is conducting on sotagliflozin in Type 1 diabetics. While the results were not flawless, they looked to me to be broadly consistent with the prior inTandem1 study and good enough to support eventual FDA approval and commercial success.

The inTandem2 study showed a 0.36% placebo-adjusted reduction in HbA1c for the 200mg dosage and a 0.34% placebo-adjusted reduction in the 400mg group. Those results were broadly similar to the results seen in the inTandem1 study (a 0.35% and 0.41% placebo-adjusted reduction) in a basically similar patient population. That there was/is no meaningful separation between the 200mg and 400mg groups could be a potential source of disappointment, as the lack of a distinctly better response at 400mg could conceivably reduce the sales potential. That said, there hasn’t been a study of whether those who don’t respond adequately to the 200mg dose respond at the 400mg dose, so that could still be an option.

Top 5 Medical Stocks To Watch Right Now: Treehouse Foods, Inc.(THS)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Treehouse Foods (THS) , TG Therapeutics (TGTX) , Kinder Morgan (KMI) , Magellan Midstream Partners (MMP) , Chesapeake Energy (CHK) and Arconic (ARNC) .

Top 5 Medical Stocks To Watch Right Now: Cardtronics, Inc.(CATM)

Advisors’ Opinion:

  • [By Timothy Green]

    Non-bank ATM operator Cardtronics (NASDAQ:CATM) slumped on Friday despite reporting fourth-quarter results that beat analyst estimates on all fronts. The culprit driving the decline may be the company’s 2017 guidance, which calls for a decline in adjusted EPS. At 2:30 p.m. EST, the stock was down about 10%.

Top 5 Medical Stocks To Watch Right Now: Graco Inc.(GGG)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, industrials shares fell by 0.83 percent. Meanwhile, top losers in the sector included Graco Inc. (NYSE: GGG), down 9 percent, and Southwest Airlines Co (NYSE: LUV), down 11 percent.

  • [By Joel Elconin]

    At this time, the only relevant news to the Gold market and Gold stocks was the halt of Graco Inc. (NYSE: GGG), which was down $0.80 at $84.64 and just reopened at $82.20.

Top 5 Medical Stocks To Watch Right Now: Globe Specialty Metals Inc.(GSM)

Advisors’ Opinion:

  • [By Dan Caplinger]

    But there are still plenty of factors that are preventing stocks overall from mounting stronger gains, including nervousness about geopolitical issues as well as weaker parts of the global economy. Nevertheless, some stocks posted strong gains, and Puma Biotechnology (NASDAQ:PBYI), Applied Optoelectronics (NASDAQ:AAOI), and Ferroglobe (NASDAQ:GSM) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By Lisa Levin]

    Shares of Ferroglobe PLC (NASDAQ: GSM) got a boost, shooting up 10 percent to $10.17 after the company posted a narrower-than-expected Q1 loss.

    Puma Biotechnology Inc (NASDAQ: PBYI) shares were also up, gaining 37 percent to $51.75 as briefing documents for Wednesday Advisory Committee meeting are published to the FDA website. The documents showed that neratinib performed better than Roche's trastuzumab in I-SPY2 trial, particularly in subgroup of patients that were HRc negative. The briefing docs also showed that study 3004 met prespecified primary efficacy endpoint.

Top 5 Medical Stocks To Watch Right Now: Outerwall Inc.(OUTR)

Advisors’ Opinion:

  • [By Monica Gerson]

    Shares of Outerwall Inc (NASDAQ: OUTR) surged over 8 percent in Monday’s after-hours trading session following news for investors the company has begun the process of exploring strategic and financial alternatives. Outerwall’s Board also announced the raising of the company’s quarterly dividend from $0.30 to $0.60 per share. Outerwall shares jumped 8.11 percent to $37.18 in the after-hours trading session.

  • [By Jake L’Ecuyer]

    Equities Trading DOWN
    Shares of Outerwall (NASDAQ: OUTR) were down 16.03 percent to $47.00 after the company lowered its forecast for the third quarter and full year. Werner Enterprises (NASDAQ: WERN) shares tumbled 4.71 percent to $23.26 after the company issued a weak third-quarter profit forecast. Bank of America downgraded the stock from Buy to Neutral. Pandora Media (NYSE: P) down, falling 1.71 percent to $23.58 as the company announced its plans to sell 14 million shares of common stock, including 4 million shares from current stockholders.

  • [By Peter Graham]

    A long term performance chart shows shares of Netflix close to all time highsgoing into earnings while potential performance peer or competitor Amazon.com, Inc (NASDAQ: AMZN) has continueda more steadyrise and small cap Outerwall Inc (NASDAQ: OUTR), which owned the Redbox business,got swallowed up Apollo Global Management, LLC (NYSE: APO) late last year:

  • [By Peter Graham]

    A long term performance chart shows shares of Netflix at all time highswhile potential performance peer or competitor Amazon.com, Inc (NASDAQ: AMZN) has continueda more steadyrise and small cap Outerwall Inc (NASDAQ: OUTR), which owned the Redbox business,was swallowed up Apollo Global Management, LLC (NYSE: APO) late last year:

  • [By Monica Gerson]

    Outerwall (NASDAQ: OUTR) dipped 19.33% to $45.15 in the pre-market session after the company lowered its forecast for the third quarter and full year.

trade stocks online

FedEx (FDX) is scheduled to release its earnings next week–and RBC’s John Barnes and team aren’t expecting great news:

FedExreports 3FQ/16 (ended February 2016) results on March 16 after market close…We are trimming our 3FQ/16 EPS estimates to reflect higher than expected peak season costs. We also expect the company to rein in FY/16 EPS guidance when it reports. Accordingly, we are cautious onFedEx into earnings next week…

FedExoperations negatively impacted by severe weather and a last minute surge in volumes the week before Christmas. In order to cope, the company ran operations of Christmas and the day after. We believe this reduced Ground margins by 70 bps. Our sense is that this was less of an issue for the Express operation…

Mid-point of guidance likely to move lower. Our new FY/16 EPS estimate of $10.43 sits near the low end of the $10.40-$10.90 guidance range. We expect management to both lower guidance and tighten the range to $10.40-10.60 even after incorporating the benefit from share repurchase activity.

trade stocks online: Pure Cycle Corporation(PCYO)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, utilities shares fell 0.46 percent. Meanwhile, top losers in the sector included Korea Electric Power Corporation (ADR) (NYSE: KEP), down 4 percent, and Pure Cycle Corporation (NASDAQ: PCYO), down 2 percent.

  • [By Jim Robertson]

    On Wednesday, our Under the Radar Moversnewsletter suggested small cap water and wastewater services stockPure Cycle Corporation (NASDAQ: PCYO) as a long/bullish trade:

trade stocks online: Oasis Petroleum Inc.(OAS)

Advisors’ Opinion:

  • [By Paul Ausick]

    Oasis Petroleum Inc. (NYSE: OAS) is rated a Buy and the price target was lifted to $24. For 2017, the net loss estimate improved from a prior $0.27 per share to $0.23 per share. The 2018 EPS estimate rose from $0.62 to $0.64. Shares closed at $14.13 on Friday. The 52-week range is $5.93 to $14.35, and the consensus 12-month target is $17.87.

  • [By Jon C. Ogg]

    Oasis Petroleum Inc. (NYSE: OAS) rose a whopping 27.8% to $14.98, and the 33.2 million shares was about 2.5 times normal volume. Oasis Petroleum has a 52-week trading range of $3.40 to $15.02 and a consensus analyst price target of $14.54. The company has a total market cap of $3.5 billion.

  • [By Chris Lange]

    Oasis Petroleum Inc. (NYSE: OAS) shares slid on Tuesday after the company announced that it would be buying into the Delaware Basin. Analysts seemed to applaud this move, despite investors sending shares into the fire. Jefferies raised its price target to $14 from $13, and Morgan Stanley raised its target to $11 from $9. RBC has an Outperform rating and raised its target to $14 from $13, while SunTrust Robinson Humphrey downgraded it to Hold from Buy. Shares were down about 14% at $8.67, in a 52-week range of $6.69 to $16.73.

  • [By Lisa Levin]

    Shares of Oasis Petroleum Inc. (NYSE: OAS) were down 14 percent to $8.60 after the company reported a 32 million share common stock offering. The company announced Delaware Basin acquisition for $946 million and also raised its Q4 production guidance.

  • [By Craig Jones]

    Jon Najarian spoke on CNBC’s “Fast Money Halftime Report” about unusually high options activity in Oasis Petroleum Inc. (NYSE: OAS).

    Traders bought around 10,000 contracts of the June 10 calls in the first half of the trading session on Thursday. The trade is unusual because the average options volume in the name is a few hundred contracts. Najarian bought the calls and is planning to hold them for two weeks.

trade stocks online: Houghton Mifflin Harcourt Company(HMHC)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Chegg Inc finallymovingabove IPO levels while potential performance benchmarks such as Houghton Mifflin Harcourt Co (NASDAQ: HMHC) and Barnes & Noble Education Inc (NYSE: BNED), a spin off from Barnes & Noble, Inc (NYSE: BKS), have seen their performance slip:

  • [By Peter Graham]

    A long term performance chart shows shares of Barnes & Noble Education and global learning stockHoughton Mifflin Harcourt Co (NASDAQ: HMHC)underperforming while Barnes & Noble is back to breakeven levels and textbook stock Chegg Inc (NYSE: CHGG) has taken off:

trade stocks online: Graco Inc.(GGG)

Advisors’ Opinion:

  • [By Joel Elconin]

    At this time, the only relevant news to the Gold market and Gold stocks was the halt of Graco Inc. (NYSE: GGG), which was down $0.80 at $84.64 and just reopened at $82.20.

  • [By Lisa Levin]

    In trading on Thursday, industrials shares fell by 0.83 percent. Meanwhile, top losers in the sector included Graco Inc. (NYSE: GGG), down 9 percent, and Southwest Airlines Co (NYSE: LUV), down 11 percent.

trade stocks online: Exactech Inc.(EXAC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Exactech, Inc. (NASDAQ: EXAC) shares were also up, gaining 31 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11

trade stocks online: Citi Trends, Inc.(CTRN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Citi Trends, Inc. (NASDAQ: CTRN) shares shot up 16 percent to $19.38 after the company posted upbeat quarterly earnings.

    Shares of Internap Corp (NASDAQ: INAP) got a boost, shooting up 13 percent to $2.97 on strong quarterly results. Stifel Nicolaus upgraded Internap from Hold to Buy and raised the price target from $2.00 to $5.50.

Top Low Price Stocks To Buy Right Now

Citigroup’s Alastair Syme and team argue that the earnings from big oil companies like Chevron (CVX), Total (TOT) and Royal Dutch Shell (RDS.A) will be bad…real bad. But that won’t stop the stocks from outperforming. They explain why:

Bloomberg News

Negative headlines, positive performance: We expect the majority of Big Oil companies to post negative 1Q16 earnings, a brutal headline, but one that clearly reflects the impact of cyclical oil price lows this quarter. The outlook can improve. Our positive thesis on the Big Oil group reflects a belief that the market still only discounts modest oil recovery we think c. $40/bbl is imbedded in valuations and a view that the group can drive self-help gains to boost profitability even in a low price environment. Signs of this self-help should be evident in 1Q operating performance: we expect to see the delivery of top-line growth (taking market share versus broader industry) and a continued reduction in operating costs, building on substantial cost-cutting through 2015.

Top Low Price Stocks To Buy Right Now: Live Nation Entertainment, Inc.(LYV)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    For his “Executive Decision” segment, Cramer checked in with Michael Rapino, president and CEO of Live Nation Entertainment (LYV) , a stock that’s up 44% since Cramer last spoke with him a little more than a year ago but also one that fell 3% in today’s session on what appeared to be solid quarterly results.

Top Low Price Stocks To Buy Right Now: Just Hold Your Nose and Dive Into Under Armour Inc (UAA)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Under Armour’s class-C shares dropped 3.2% to $18.43, while the S&P 500. Under Armour’s (UAA) class-A shares fell 2% to $19.86.

    Under Armour fired about 24 employees in its Connected Fitness unit, with most of them located in Copenhagen. That seems like a big drop for such a small act, but these days it seems like everyone except Barron’s is looking for a reasons to dump Under Armour’s shares.

  • [By Ben Levisohn]

    Count Macquarie’s Laurent Vasilescu and team among the latter. In a note today, they offered 10 reasons to be cautious about Lululemon, which they rate Underperform. Here are my excerpts:

    Same-store Sales: “We are concerned that store comps are in the low single digits, especially since the store fleet is very young,” Vasilescu warns. Margin Disclosure: “The level of disclosure around the gross margin continues to decrease,” Vasilescu claims. Margin Sapping Businesses: “Mens and ivivva are both growth drivers yet they are
    margin dilutive,” Vasilescu explains. Too many stores in the U.S.: “Prior management outlined many times the TAM of 300-350 stores in North America,”Vasilescu writes. “Lulu is reaching saturation.” U.S. Store Profitability: It’s much lower than in Canada, claims Vasilescu. Marketing: Not enough of it, especially compared to Nike (NKE), Adidas (ADDYY), and Under Armour (UAA), Vasilescu says. Not a tech company: On its third-quarter conference call, Lululemon said it was a quasi-tech company. It’s not, says Vasilescu. Competition: Denim. Beyonce. Amazon.com (AMZN). Ouch. High costs: “When comps turn negative we think this will pressure earnings, as we estimate high fixed SG&A costs,” write Vasilescu. Inventories: “Days in inventory remain elevated at 112 vs historical 3Q rate of 90,” warns Vasilescu.

    Shares of Lululemon Athletica have gained 0.6% to $64.06 at 2:32 p.m. today, while Nike has fallen 0.9% to $55.86, Adidas has dipped 0.1% to $96.27, Under Armour has risen 0.9% to $19.83, and Amazon.com has ticked up 0.1% to $846.38.

  • [By Leo Sun]

    Under Armour (NYSE:UA) (NYSE:UAA), Fitbit (NYSE:FIT), and GoPro (NASDAQ:GPRO) were all terrible stocks to own over the past year. Under Armour and Fitbit were both cut in half, and GoPro plummeted nearly 40%.

  • [By Brian Withers]

    High-performance athletic clothing brand Under Armour (NYSE:UA) (NYSE:UAA) reported slightly better earnings than expected for the first quarter. As covered in my earnings preview article, investors were interested in the results from its large North American and wholesale segments. Management discussed these topics along with providing insight into the new relationship with Kohl’s. Missing was insight into retail traffic, specific results on what’s happening in North America, and results from company’s e-commerce efforts. All the while, Under Armour’s largest competitor, Nike, and its biggest partner, Dick’s Sporting Goods, are openly discussing e-commerce trends and results.

  • [By Dustin Blitchok]

    Prior to Wednesday’s unraveling of the manufacturing council, six executives had resigned:

    On June 1, Tesla Inc (NASDAQ: TSLA) CEO Elon Musk dropped out following Trump’s decision to withdraw the U.S. from the Paris climate accord. “Leaving Paris is not good for America or the world,” Musk tweeted.
    Merck & Co., Inc. (NYSE: MRK) CEO Ken Frazier drew fire from Trump on Twitter after leaving the council. “Now that Ken Frazier of Merck Pharma has resigned from President's Manufacturing Council,he will have more time to LOWER RIPOFF DRUG PRICES!" the president tweeted.
    When Frazier left the council, he said: “I feel a responsibility to take a stand against intolerance and extremism.”
    On Aug. 14, Under Armour Inc (NYSE: UAA) CEO Kevin Plank resigned. “I love our country & company,” Plank said. “I am stepping down from the council to focus on inspiring & uniting through power of sport.”
    Intel Corporation (NASDAQ: INTC) CEO Brian Krzanich left Aug. 14 and said: “I stand with others for equality and improving U.S. competitiveness. Both require improving in today’s environment.”
    Alliance for American Manufacturing President Scott Paul quit Aug. 15, stating: “I’m resigning from the Manufacturing Jobs Initiative because it’s the right thing for me to do.”
    AFL-CIO President Richard Trumka resigned the same day as Paul. “We cannot sit on a council for a president who tolerates bigotry and domestic terrorism,” Trumka said.

    Image: Gage Skidmore, Flickr

Top Low Price Stocks To Buy Right Now: Graco Inc.(GGG)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, industrials shares fell by 0.83 percent. Meanwhile, top losers in the sector included Graco Inc. (NYSE: GGG), down 9 percent, and Southwest Airlines Co (NYSE: LUV), down 11 percent.

  • [By Joel Elconin]

    At this time, the only relevant news to the Gold market and Gold stocks was the halt of Graco Inc. (NYSE: GGG), which was down $0.80 at $84.64 and just reopened at $82.20.

Top Low Price Stocks To Buy Right Now: Iridium Communications Inc(IRDM)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap satellite stock Iridium Communications (NASDAQ: IRDM) reportedQ2 2017 earnings before the market opened on Thursday with results beating expectations. Total revenueincreased 2% to $111.6 million which consisted of $86.6 million of service revenue and $25.0 million of revenue related to equipment sales and engineering and support projects.Service revenue, which represents primarily recurring revenue from Iridium’s growing subscriber base, grew 4% and was 78% of total revenue. The Company ended the quarter with 913,000 total billable subscribers, which compares to 823,000 for the year-ago period and is up from 869,000 for the quarter ended March 31, 2017.Total billable subscribers grew 11% year-over-year, driven by growth in M2M and government customers. Net income was $24.8 million versus $26.9 million for the second quarter of 2016. The CEO commented:

  • [By Jim Robertson]

    Trump’s proposal to spin off air traffic control from the Federal Aviation Administration (FAA) bodes well for small cap satellite stock Iridium Communications (NASDAQ: IRDM), but theres a bigger opportunity for the Company in theInternet of Things (IoT) space. Technology company Harris Corporation (NYSE: HRS) is already a leading candidate to supply the FAA with real-time aircraft tracking data in partnership with Iridium Communications with the latter having a joint venture that has partnered with air traffic control authorities in Canada, Italy, Ireland and Denmark to provide air traffic surveillance (in cooperation with Harris).

best stock investments

How Outside Business Activities Doomed a UBS Advisor

The Best and Worst ETFs of 2016: Morningstar

It’s 2017. Do You Know Your Clients’ Tax Brackets?

Though the past 12 months have been full of unexpected news, they generally have been good for U.S. equities, according to Morningstar. In fact, the S&P 500 is up about 13% through Dec. 23. Plus, the small-cap-oriented Russell 2000 Index has roared ahead over 22%.

How have these gains played out in different sectors and fund groups? Morningstar analyst Andrew Daniels, a CFA and CMA, breaks down the results in an online report on equity performance, which he published Friday.

As for dividend-heavy consumer defensive and real estate stocks, they also have had a poor showing in 2016 vs. other sections, though both are still up 6% or more thanks to raising interest rates.

Morningstar Style Boxes

The ‘valedictorian of the ETF class of 2016’ is Vanguard’s VIGI, with its low cost and strong ‘moat,’ writes Ben…

best stock investments: Graco Inc.(GGG)

Advisors’ Opinion:

  • [By Joel Elconin]

    At this time, the only relevant news to the Gold market and Gold stocks was the halt of Graco Inc. (NYSE: GGG), which was down $0.80 at $84.64 and just reopened at $82.20.

  • [By Lisa Levin]

    In trading on Thursday, industrials shares fell by 0.83 percent. Meanwhile, top losers in the sector included Graco Inc. (NYSE: GGG), down 9 percent, and Southwest Airlines Co (NYSE: LUV), down 11 percent.

best stock investments: Atlas Air Worldwide Holdings(AAWW)

Advisors’ Opinion:

  • [By Paul Ausick]

    Amazon leased 40 planes from Air Transport Services Group Inc. (NASDAQ: ATSG) and Atlas Air Worldwide Holdings Inc. (NASDAQ: AAWW). Each carrier is supplying 20 Boeing jets to Prime Air.

best stock investments: Granite Construction Incorporated(GVA)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Despite a lack of conviction in the market at large, some stocks posted sharp gains on Friday, and Diana Shipping (NYSE:DSX), Akorn (NASDAQ:AKRX), and Granite Construction (NYSE:GVA) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By David Zeiler]

    Construction stocks Fluor (NYSE: FLR) and Granite Construction Inc. (NYSE: GVA) both rose about 8%; Vulcan Materials Co. (NYSE: VMC) jumped nearly 10%.

best stock investments: Zions Bancorporation(ZION)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    In the super-regional banks that are not money center banks, Regions Financial Corp. (NYSE: RF) was up 6.3% at $13.22, and Zions Bancorporation (NASDAQ: ZION) was last seen up 3.8% at $38.30. They would both do better with lower regulatory costs and be able to better compete against larger banks when their stress test results had not been as strong.

  • [By Nelson Hem]

    See what Barron's feels the prospects are for Energy Transfer Partners LP (NYSE: ETP) if it cuts its distribution and dumps its general partner, and salesforce.com, inc. (NYSE: CRM) with its generous potential upside. Also whether regional banks like Zions Bancorp (NASDAQ: ZION) could see a boost from a proposed regulatory change, and the sweetheart deal the Koch brothers got with Meredith Corporation (NYSE: MDP).

Top 5 Medical Stocks To Invest In Right Now

With increasing legislation legalizing marijuana both in Canada and the United States, companies involved in the development of cannabis for medical and other purposes are gaining attention.

But weed stocks, as they are often referred to, have been taking a beating lately, with data showing that many of the stock dumps are sales by executives of major cannabis companies. Is this profit taking, or a reaction to AG Jeff Sessions, who has been an outspoken opponent of legalized marijuana, implying that he might consider a rollback to restore marijuana laws under federal jurisdiction? Its anybodys guess. But rather than rush to unload a company before it goes up in smoke (see what I did there) its worth taking a look at additional assets that a cannabis company may hold.

Top 5 Medical Stocks To Invest In Right Now: American Assets Trust, Inc.(AAT)

Advisors’ Opinion:

  • [By Markus Aarnio]

    Owens Realty Mortgage’s competitors include American Assets Trust (AAT), Alexandria Real Estate Equities (ARE) and Boston Properties (BXP). American Assets Trust has seen five insider buy transactions and four insider sell transactions this year. American Assets Trust has a dividend yield of 2.78%. Alexandria Real Estate Equities has seen 14 insider sell transactions this year. Alexandria Real Estate Equities has a dividend yield of 4.10%. Boston Properties has seen one insider buy transaction and four insider sell transactions this year. Boston Properties has a dividend yield of 2.43%.

Top 5 Medical Stocks To Invest In Right Now: Old Second Bancorp Inc.(OSBC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Friday afternoon, the financial sector proved to be a source of strength for the market. Leading the sector was strength from Wins Finance Holdings Inc (NASDAQ: WINS) and Old Second Bancorp Inc. (NASDAQ: OSBC).

Top 5 Medical Stocks To Invest In Right Now: Spark Therapeutics, Inc.(ONCE)

Advisors’ Opinion:

  • [By Chris Lange]

    Spark Therapeutics Inc. (NASDAQ: ONCE) saw its shares take a big step back on Monday after the firm reported less than favorable results at the American Society of Hematology (ASH) annual meeting. Analysts have taken this opportunity to weigh in on the stock:

  • [By Jim Robertson]

    On Wednesday, our Elite Opportunity Pronewsletter suggested going long again on small cap gene therapy stock Spark Therapeutics (NASDAQ: ONCE):

    Financially, Spark Therapeutics has over $300M in cash on the books and no debt to speak of yet, which equates to a share price of just over four times cash. The Company has generated over $20M in revenue for the trailing twelve months, and although the Company is expected to continue to lose money for the next few years, any strong clinical data that hits the tape could rocket shares of ONCE overnight, just like we’ve seen with so many others over the years.

  • [By Lisa Levin]

    Shares of Spark Therapeutics Inc (NASDAQ: ONCE) were down 36 percent to $47.08 on preliminary SPK-8011 trial data.

    Athenex Inc (NASDAQ: ATNX) was down, falling around 13 percent to $13.95. Almirall and Athenex reported a strategic partnership to develop and commercialize KX2-391 in the U.S. and Europe.

  • [By Paul Ausick]

    Spark Therapeutics Inc. (NASDAQ: ONCE) dropped 44% Monday to post a new 52-week low of $41.06 after closing at $73.38 on Friday. The 52-week high is $91.75. Volume was around 13.5 million, nearly 30 times the daily average of about 480,000. The company’s hemophilia A drug posted disappointing trial results.

Top 5 Medical Stocks To Invest In Right Now: Graco Inc.(GGG)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, industrials shares fell by 0.83 percent. Meanwhile, top losers in the sector included Graco Inc. (NYSE: GGG), down 9 percent, and Southwest Airlines Co (NYSE: LUV), down 11 percent.

  • [By Joel Elconin]

    At this time, the only relevant news to the Gold market and Gold stocks was the halt of Graco Inc. (NYSE: GGG), which was down $0.80 at $84.64 and just reopened at $82.20.

Top 5 Medical Stocks To Invest In Right Now: Inphi Corporation(IPHI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Technology shares rose by 1.9 percent in the US market on Friday. Top gainers in the sector included Fabrinet (NYSE: FN), and Inphi Corporation (NYSE: IPHI).

  • [By Roberto Pedone]

    Inphi (IPHI) provides high-speed analog and mixed signal semiconductor solutions for the communications, datacenter and computing markets. This stock closed up 4.7% at $13.25 in Monday’s trading session.

    Monday’s Volume: 838,000

    Three-Month Average Volume: 202,080

    Volume % Change: 378%

    From a technical perspective, IPHI jumped higher here right above some near-term support at $12.44 with heavy upside volume. This stock has been uptrending strong for the last five months, with shares soaring higher from its low of $8.62 to its intraday high of $13.85. During that uptrend, shares of IPHI have been consistently making higher lows and higher highs, which is bullish technical price action. That move briefly pushed shares of IPHI into breakout territory, since the stock flirted with some near-term overhead resistance at $13.50.

    Traders should now look for long-biased trades in IPHI as long as it’s trending above some near-term support at $12.44 and then once it sustains a move or close above its new 52-week high at $13.85 with volume that hits near or above 202,080 shares. If we get that move soon, then IPHI will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are its next major overhead resistance levels at $14.79 to $16.94, or possibly even $18.

Top 10 Casino Stocks To Invest In Right Now

What happened

Shares ofPenn National Gaming, Inc. (NASDAQ:PENN), casino operator and equipment maker largely focused on slot machines, climbed 28% throughout March, according to data fromS&P Global Market Intelligence, after the company announced that it raised financial guidance for the first quarter of 2017 ending March 31.

So what

About a week before the quarter ended, Penn management released updated estimates for the quarter, including revenue of $771 million on the upper end of the range, which was up from the previous guidance of $761 million, and would be about 2% higher than Q1 2016. The company also raised its Adjusted EBITDA guidance from$209.3 million to an expected range of$222 million and $223 million.Penn’s official Q1 earnings are expected to be released on April 27, and during that earnings release, the company will give full-year 2017 guidance.

Image source: Getty Images.

Top 10 Casino Stocks To Invest In Right Now: Express-1 Expedited Solutions Inc.(XPO)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on GlaxoSmithKline (GSK) , Chubb (CB) , XPO Logistics (XPO) , FedEx (FDX) and Nordson (NDSN) .

    Cramer was bearish on Prudential (PRU) , Advanced Semiconductor Engineering (ASX) and ZTO Express (ZTO) .

  • [By WWW.THESTREET.COM]

    With a trailing 12-month price-to-earnings ratio of 28.79, FedEx’s valuation is in line with UPS (27.52) and far cheaper than XPO Logistics (XPO) (90.25).

Top 10 Casino Stocks To Invest In Right Now: Graco Inc.(GGG)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, industrials shares fell by 0.83 percent. Meanwhile, top losers in the sector included Graco Inc. (NYSE: GGG), down 9 percent, and Southwest Airlines Co (NYSE: LUV), down 11 percent.

  • [By Joel Elconin]

    At this time, the only relevant news to the Gold market and Gold stocks was the halt of Graco Inc. (NYSE: GGG), which was down $0.80 at $84.64 and just reopened at $82.20.

Top 10 Casino Stocks To Invest In Right Now: Evercore Partners Inc(EVR)

Advisors’ Opinion:

  • [By Diane Alter]

    The New York Times first reported that Frontier Airlines is prepping for an initial public offering. The Denver, Colo.-based low-cost carrier has hired Deutsch Bank (NYSE: DB), JPMorgan Chase & Co. (NYSE: JPM), and Evercore Partners Inc. (NYSE: EVR) to handle the IPO. The airline started the process late last year when it approached a number of bankers.

Top 10 Casino Stocks To Invest In Right Now: Foresight Energy LP(FELP)

Advisors’ Opinion:

  • [By Laurie Kulikowski]

    FORESIGHT ENERGY LP has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. This company has reported somewhat volatile earnings recently. We feel it is likely to report a decline in earnings in the coming year. During the past fiscal year, FORESIGHT ENERGY LP increased its bottom line by earning $0.78 versus $0.08 in the prior year. For the next year, the market is expecting a contraction of 67.9% in earnings ($0.25 versus $0.78).

     

  • [By Laurie Kulikowski]

    Despite any intermediate fluctuations, we have only bad news to report on this stock’s performance over the last year: it has tumbled by 83.17%, worse than the S&P 500’s performance. Consistent with the plunge in the stock price, the company’s earnings per share are down 82.85% compared to the year-earlier quarter. Naturally, the overall market trend is bound to be a significant factor. However, in one sense, the stock’s sharp decline last year is a positive for future investors, making it cheaper (in proportion to its earnings over the past year) than most other stocks in its industry. But due to other concerns, we feel the stock is still not a good buy right now.

     

  • [By Laurie Kulikowski]

    After the recent distribution cut, Foresight’s distribution coverage is over 6.0x with much of the future cash flow dedicated to reducing leverage. It has over 80% of its coal sales priced for next year and its costs should improve as the low cost Hillsboro mine comes back into production early next year. It is also benefitting from cost synergies with the Murray operations. We believe Foresight’s new distribution level is sustainable. With its 15.5% yield, we feel FELP could be attractive to income seeking investors. 

  • [By Laurie Kulikowski]

    The change in net income from the same quarter one year ago has exceeded that of the Oil, Gas & Consumable Fuels industry average, but is less than that of the S&P 500. The net income has significantly decreased by 82.3% when compared to the same quarter one year ago, falling from $45.72 million to $8.07 million.

     

  • [By Laurie Kulikowski]

    We rate FORESIGHT ENERGY LP as a Sell with a ratings score of E+. This is based on a variety of negative investment measures, which should drive this stock to significantly underperform the majority of stocks that we rate. The company’s weaknesses can be seen in multiple areas, such as its generally high debt management risk, poor profit margins, generally disappointing historical performance in the stock itself, deteriorating net income and feeble growth in its earnings per share. 

  • [By Laurie Kulikowski]

    The debt-to-equity ratio is very high at 18.59 and currently higher than the industry average, implying increased risk associated with the management of debt levels within the company. To add to this, FELP has a quick ratio of 0.56, this demonstrates the lack of ability of the company to cover short-term liquidity needs.

     

Top 10 Casino Stocks To Invest In Right Now: iAnthus Capital Holdings, Inc. (ITHUF)

Advisors’ Opinion:

  • [By Javier Hasse]

    Earlier this month, cannabis-focused financing and advisory firm iAnthus Capital Holdings Inc (CNSX: IAN) (OTC: ITHUF) announced it acquired Westchester-based Valley Agriceuticals, LLC, gaining access to New York’s nascent cannabis market.

  • [By Javier Hasse]

    The Green Solution received a $7.5 million loan facility from iAnthus Capital Holdings Inc (OTC: ITHUF).

    “This was also to accelerate expansion within Colorado and going into other states nation-wide.”

    Valens Groworks Corp (CNSX: VGW), a Canadian post-inspection applicant for cannabis cultivation and processing, raised C$500,000 ($381,431) under a convertible note to meet acquisition and expansion obligations.

  • [By Javier Hasse]

    Over the past few weeks, Benzinga has been sharing interviews with the top venture capital and investment firms operating in the cannabis industry. Among those focused on ancillary businesses that do not touch the plant, we profiled Snoop Dogg’s Casa Verde and Arcview Group partner, CanopyBoulder. Among those willing to get involved in plant-touching ventures, we presented MJIC, which claims it intends to become the “Amazon.com, Inc. (NASDAQ: AMZN) of weed,” and iAnthus Capital Holdings Inc (CNSX: IAN) (OTC: ITHUF), which raises capital for U.S.-based marijuana companies in Canadian capital markets.

Top 10 Casino Stocks To Invest In Right Now: JinkoSolar Holding Company Limited(JKS)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    First Solar, Inc (NASDAQ: FSLR) was trading down 3.7 percent Monday, while JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) was down 0.8 percent, SunPower Corporation (NASDAQ: SPWR) 4.4 percent, Canadian Solar Inc. (NASDAQ: CSIQ) 5.2 percent and JinkoSolar Holding Co., Ltd. (NYSE: JKS) 4.4 percent.

  • [By Paul Ausick]

    It is not often that a secondary stock offering sends a companys shares higher, but we are seeing that very phenomenon Friday morning. Chinese solar PV maker JinkoSolar Holding Co. Ltd. (NYSE: JKS) and stock image company Shutterstock Inc. (NASDAQ: SSTK) both priced secondary offerings this morning and shares in both companies have risen sharply.

  • [By Lisa Levin]

    In trading on Monday, energy shares fell by 0.59 percent. Meanwhile, top losers in the sector included JinkoSolar Holding Co., Ltd. (NYSE: JKS), down 8 percent, and Teekay Offshore Partners L.P. (NYSE: TOO) down 7 percent.

  • [By Lisa Levin]

    JinkoSolar Holding Co (NYSE: JKS) dropped 9.88% to $16.87 after the company announced the offering of 3,500,000 American Depositary Shares.

    Fuwei Films (Holdings) Co (NASDAQ: FFHL) dropped 9.66% to $1.30. Fuwei Films’ trailing-twelve-month ROE is -10.85%.

  • [By Paul Ausick]

    But the real news is the near vertical trajectory in share prices for the two stocks. This could be another manifestation of the markets hunger for some momentum plays, as we noted earlier this morning the bump to share prices for both JinkoSolar Holding Co. Ltd. (NYSE: JKS) and Shutterstock Inc. (NASDAQ: SSTK), both of which held secondary share sales this morning.

Top 10 Casino Stocks To Invest In Right Now: Ligand Pharmaceuticals Incorporated(LGND)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Monday, healthcare shares were relative laggards, down on the day by about 0.51 percent. Meanwhile, top losers in the sector included Ligand Pharmaceuticals Inc. (NASDAQ: LGND), down 8 percent, and ImmunoGen, Inc. (NASDAQ: IMGN) down 7 percent.

  • [By Lisa Levin]

    Ligand Pharmaceuticals Inc. (NASDAQ: LGND) shares dropped 6 percent to $132.26. Deutsche Bank downgraded Ligand Pharmaceuticals from Hold to Sell.

  • [By Keith Speights]

    Research and development is the lifeblood of biotech companies. The potential for new drugs also serves as a primary factor driving biotech stocks higher and higher. That’s been the case for Celgene (NASDAQ:CELG), Ionis Pharmaceuticals (NASDAQ:IONS), and Ligand Pharmaceuticals (NASDAQ:LGND).

Top 10 Casino Stocks To Invest In Right Now: J.B. Hunt Transport Services Inc.(JBHT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Here is the list of stocks going ex-dividend on August 3, 2016.

    J B Hunt Transport Services Inc (NASDAQ: JBHT) – $0.2200 dividend, 1.0791 percent yield
    Johnson Controls Inc (NYSE: JCI) – $0.2900 dividend, 2.6250 percent yield
    FirstEnergy Corp. (NYSE: FE) – $0.3600 dividend, 3.9680 percent yield
    Sunoco LP (NYSE: SUN) – $0.8255 dividend, 10.7347 percent yield
    Wells Fargo & Co (NYSE: WFC) – $0.3800 dividend, 3.1588 percent yield
    BP plc (ADR) (NYSE: BP) – $0.6000 dividend, 6.8768 percent yield
    American Airlines Group Inc (NASDAQ: AAL) – $0.1000 dividend, 1.1442 percent yield
    Heidrick & Struggles International, Inc. (NASDAQ: HSII) – $0.1300 dividend, 2.9834 percent yield
    Alcoa Inc (NYSE: AA) – $0.0300 dividend, 1.1321 percent yield
    Sensient Technologies Corporation (NYSE: SXT) – $0.2700 dividend, 1.5341 percent yield

    Posted-In: Ex-DividendNews Dividends Markets Trading Ideas

Top 10 Casino Stocks To Invest In Right Now: eLong, Inc.(LONG)

Advisors’ Opinion:

  • [By Monica Gerson]

    eLong, Inc. (ADR) (NASDAQ: LONG) is projected to post a quarterly loss at $0.60 per share on revenue of $38.31 million.

    Qunar Cayman Islands Ltd (NASDAQ: QUNR) is expected to post a quarterly loss at $8.89 per share on revenue of $1.11 billion.

Top 10 Casino Stocks To Invest In Right Now: NewStar Financial, Inc.(NEWS)

Advisors’ Opinion:

  • [By Lisa Levin] Related AHT 25 Biggest Mid-Day Gainers For Friday Mid-Day Market Update: Hortonworks Drops Following Weak Results; Freshpet Shares Spike Higher Ashford Hospitality Trust's (AHT) CEO Montgomery Bennet on Q2 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related NEWS Mid-Morning Market Update: Markets Open Higher; Micron To Lower Jobs Mid-Morning Market Update: Markets Open Lower; Broadcom Profit Beats Expectations NewStar Financial's (NEWS) CEO Tim Conway on Q2 2016 Results – Earnings Call Transcript (Seeking Alpha)

     

technical analysis

Someone asked me the other day why I thought Alibaba (NYSE:BABA) was such a huge winner in the China e-commerce game. I see three reasons.

Trust. For a long time, people in China were wary of e-commerce in China because they were simply afraid of getting ripped off when buying goods sight unseen. We didn’t really face that issue in the US to the same extent, because Sears, Wards, and J.C. Penney had been selling goods to Americans sight-unseen for over a century. Over that time, we had not only discovered which mail-order brands we could trust to “deliver the goods,” we also compelled the creation of terms, conditions, and practices that formed an (often unspoken) contract between retailer and buyer. When it created Taobao, Alibaba put together a series of terms and conditions that allowed both early adopters and the mass market to trust them enough to send their money into the ether. That trust went deep enough that, with Alipay, Chinese now trust Alibaba with their money. Experience. Alibaba understood from the outset that it needed to offer a an efficient and enjoyble buying experience, but that it did not need to go crazy. The company understood that it had a low bar. The Chinese retail experience always was miserable, and has improved only a little over the past two decades. Simply by making the experience a bit better than what you get at a typical Chinese retail store, and spending the rest of their effort on reliability and trust, Alibaba won. Scope. As Jeff Bezos understood, the key to winning in electronic commerce was not to focus on being the best bookstore, or grocery store, or anything store. The key was becoming the go-to place to shop, regardless of what you want to buy. Alibaba used Taobao to build unmatchable scope in a very short period of time. Now the default choices are traditional retail and Taobao, and everyone else has to fight harder for consideration, even as a specialized niche site.

It is difficult to see how anyone might knock that wall down.

technical analysis: Interpublic Group of Companies, Inc. (The)(IPG)

Advisors’ Opinion:

  • [By Paul Ausick]

    The Interpublic Group of Companies Inc. (NYSE: IPG) dropped about 2.3% Thursday to post a new 52-week low of $20.94 after closing Wednesday at $21.44. The 52-week high is $25.71. Volume reached nearly 13 million shares traded, nearly 3 times the daily average of around 3.8 million. The company had no specific news, but Tuesday’s weak earnings report continues to weigh on the share price.

  • [By Laurie Kulikowski]

    Net operating cash flow has significantly increased by 59.42% to $280.90 million when compared to the same quarter last year. In addition, INTERPUBLIC GROUP OF COS has also vastly surpassed the industry average cash flow growth rate of 8.14%.

     

  • [By Laurie Kulikowski]

    Despite its growing revenue, the company underperformed as compared with the industry average of 7.2%. Since the same quarter one year prior, revenues slightly increased by 1.3%. This growth in revenue does not appear to have trickled down to the company’s bottom line, displayed by a decline in earnings per share.

     

  • [By Laurie Kulikowski]

    The debt-to-equity ratio is somewhat low, currently at 0.94, and is less than that of the industry average, implying that there has been a relatively successful effort in the management of debt levels. Although the company had a strong debt-to-equity ratio, its quick ratio of 0.96 is somewhat weak and could be cause for future problems.

     

technical analysis: Principal Financial Group Inc(PFG)

Advisors’ Opinion:

  • [By Ben Levisohn]

    The twenty stocks in Worth’s basket are: Ameriprise Financial (AMP) Bank of America, Banner (BANR), Citigroup, Citizens Financial Group (CFG), East West Bancorp (EWBC), First NBC Bank Holding (FNBC), HFF (HF), KeyCorp(KEY), Legacy Texas Financial Group (LTXB), Lincoln National (LNC), Morgan Stanley, Old National Bancorp (ONB), PacWest Bancorp (PACW), PNC Financial Services Group (PNC), Principal Financial Group (PFG), Stifel Financial (SF), SVB Financial Group (SIVB), TCF Financial (TCB), and Wells Fargo.

technical analysis: Rowan Companies Inc.(RDC)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Go back a year, and offshore drillers like Noble (NE), Rowan (RDC), Transocean (RIG) and Atwood Oceanics (ATW) had been all but written off–until they weren’t anymore. Since then, investors have been rewarded for picking winners in the group from the losers, as Atwood Oceanics has more than doubled, Transocean has gained 34%, and Rowan has risen 42%, while Noble and Diamond Offshore Drilling (DO) have dropped 13%.

  • [By Jon C. Ogg]

    Rowan Companies plc (NYSE: RDC) closed up 15.1% at $17.84 and the 5.2 million shares traded was just 1.3 times normal trading volume. Rowan has a consensus analyst price target of $15.04 and a 52-week trading range of $10.67 to $20.88. The company has a total market cap of $2.2 billion.

technical analysis: Foresight Energy LP(FELP)

Advisors’ Opinion:

  • [By Laurie Kulikowski]

    After the recent distribution cut, Foresight’s distribution coverage is over 6.0x with much of the future cash flow dedicated to reducing leverage. It has over 80% of its coal sales priced for next year and its costs should improve as the low cost Hillsboro mine comes back into production early next year. It is also benefitting from cost synergies with the Murray operations. We believe Foresight’s new distribution level is sustainable. With its 15.5% yield, we feel FELP could be attractive to income seeking investors. 

  • [By Laurie Kulikowski]

    The debt-to-equity ratio is very high at 18.59 and currently higher than the industry average, implying increased risk associated with the management of debt levels within the company. To add to this, FELP has a quick ratio of 0.56, this demonstrates the lack of ability of the company to cover short-term liquidity needs.

     

  • [By Laurie Kulikowski]

    We rate FORESIGHT ENERGY LP as a Sell with a ratings score of E+. This is based on a variety of negative investment measures, which should drive this stock to significantly underperform the majority of stocks that we rate. The company’s weaknesses can be seen in multiple areas, such as its generally high debt management risk, poor profit margins, generally disappointing historical performance in the stock itself, deteriorating net income and feeble growth in its earnings per share. 

technical analysis: Envision Healthcare Holdings, Inc.(EVHC)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Even on a day like today, somebody had to be the worst performer in the S&P 500, and today that somebody is Envision Healthcare (EVHC), which missed earnings forecasts last night.

  • [By Lisa Levin]

    Envision Healthcare Holdings Inc (NYSE: EVHC) shares shot up 211 percent to $70.15. Envision Healthcare and Amsurg Corp (NASDAQ: AMSG) reported the completion of their merger.

  • [By Paul Ausick]

    Envision Healthcare Corp. (NYSE: EVHC) dropped about 9.3% Tuesday to post a new 52-week low of $43.22 after closing Monday at $47.67. The 52-week high is $74.75. Volume of around 10 million shares traded was about six times the daily average. The company had no specific news.

technical analysis: Graco Inc.(GGG)

Advisors’ Opinion:

  • [By Joel Elconin]

    At this time, the only relevant news to the Gold market and Gold stocks was the halt of Graco Inc. (NYSE: GGG), which was down $0.80 at $84.64 and just reopened at $82.20.

  • [By Lisa Levin]

    In trading on Thursday, industrials shares fell by 0.83 percent. Meanwhile, top losers in the sector included Graco Inc. (NYSE: GGG), down 9 percent, and Southwest Airlines Co (NYSE: LUV), down 11 percent.

stock market

Earnings Season Wrap Up- The last batch of third quarter earnings get announced this week, putting an end to another strong season. On Monday, Palo Alto Networks and Intuit report earnings. On Tuesday, Lowes, Dollar Tree, Salesforce and HP are scheduled to announce. And on Wednesday, John Deere reports its third quarter figures.

Tax Reform Update- After the House passed their version of the tax bill last Thursday, it’s now up to the Senate to have their say. Congressional Republicans are still aiming to have a bill on the President’s desk to sign by Christmas which means that changes should come sooner rather than later. A major change that just got proposed yesterday was the willingness to remove the provision that removes the ObamaCare individual mandate. Stay tuned to our Facebook page as these updates keep rolling in.

Economic Data Dump- Although the trading week is cut short by the holiday, the economic calendar is still quite full. On Tuesday, the National Association of Realtors report their U.S. existing home sales figures for October. This comes after last month when they reported the first decline in sales since July 2016. And then on Wednesday, U.S. durable goods orders are scheduled to be released as well as the Fed minutes from its Oct 31-Nov 1 meeting. Is a December rate hike still on the table? Find out Wednesday.

stock market: Nature's Sunshine Products, Inc.(NATR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Tuesday. Top gainers in the sector included Nature's Sunshine Prod. (NASDAQ: NATR), Bridgford Foods Corporation (NASDAQ: BRID), and SunOpta, Inc. (USA) (NASDAQ: STKL).

stock market: Graco Inc.(GGG)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, industrials shares fell by 0.83 percent. Meanwhile, top losers in the sector included Graco Inc. (NYSE: GGG), down 9 percent, and Southwest Airlines Co (NYSE: LUV), down 11 percent.

  • [By Joel Elconin]

    At this time, the only relevant news to the Gold market and Gold stocks was the halt of Graco Inc. (NYSE: GGG), which was down $0.80 at $84.64 and just reopened at $82.20.

stock market: TESARO, Inc.(TSRO)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Guggenheim’s Tony Butler and Kaitlin Sandor argue that Gilead Sciences (GILD) should buy Syndax Pharmaceuticals (SNDX), Corvus Pharmaceuticals (CRVS), and Tesaro (TSRO) to solve its problem of slowing sales:

  • [By Ben Levisohn]

    Who has PARP? A poly ADP-ribose polymerase inhibitor (PARPi) kills cancer cells by interfering tumor DNA repair pathway with the potential to treat ovarian, breast and prostate cancer. Studies have shown that patients with BRCA mutations (BRCAmut) respond to PARPi. AstraZenecas (AZN) PARPi was approved in 2014 whileClovis Oncology (CLVS) and Tesaro (TSRO) both have positive Phase III data. Clovis licensed its PARPi from Pfizer (PFE) in 2011 and Tesaro licensed its PARPi from Merck (MRK) in 2012, after Sanofis (SNY) PARPi (later demonstrated that it cannot block PARP) failed in Phase III in early 2011.

  • [By George Budwell]

    Unfortunately for Clovis and its shareholders, though, Astra’s Lynparza is currently underpriority review with the FDA as a maintenance therapy in ovarian cancer, andTesaro’s (NASDAQ:TSRO)rival PARP inhibitor Zejula gained an early approval– along with afar broader label than Rubraca — just this week.

  • [By Ben Levisohn]

    Shares of Tesaro (TSRO) are soaring today after the biotech company reported positive data for its treatment of ovarian cancer over the weekend. Credit Suisse analyst Alethia Young and team contend that “M&A remains in focus” for Tesaro following the data:

    Getty Images

    We are increasing our target price to $122 from $90 as we move to an M&A DCF valuation. We were at ESMO this weekend, and we believe the big takeaway on Tesaro data is that it works broadly in all 2L ovarian populations and safety looks solid. We also think the robustness of this data bodes well from PRIMA and QUADRA but are maintaining our POS here. We have looked at our model and also adjusted durations in first-line. We think Tesaro remains one of the most attractive and de-risked cancer assets in our landscape and the company has been cited in major press sources as a takeout target (Bloomberg, Investor Business Daily).

    We think M&A remains in focus for Tesaro. Our M&A DCF valuations range from $122 to $157 by our model. We have also built models for other cancers like NSCLC, SCLC, prostate, and others where PARP might be impactful. We assume 0% POS for now but we conservatively see at least another $1B in sales from PARP expansion. Tesaro has been cited in the press as a potential M&A target and is a company we frequently hear mentioned as a target from our conversations. We think the demand for late stage oncology assets is high, especially in the PARP space given the potential for activity across a range of tumors. For a large Pharma player who already has an oncology salesforce and large R&D infrastructure we could see SG&A synergies of 50-75% and R&D synergies of 15-30%. In our base case TSRO P&L we model a tax rate of 30% so there could be synergies here as well. Two additional key swing factors which might be included in a CVR are how much expansion from PARP in other cancers and immuno-oncology…

    Ex M&A,

  • [By Todd Campbell]

    The PARP battle is on. Following news that AstraZeneca’s (NYSE:AZN) PARP-inhibiting cancer drug Lynparza delivered a big win in phase 3 studies, all eyes now shift to how a potential Food and Drug Administration approval for Lynparza will reshape the commercial opportunity for competitor Tesaro Inc. (NASDAQ:TSRO).

  • [By Todd Campbell]

    Tesaro’s (NASDAQ:TSRO)ovarian cancer drug, niraparib, will begin competing for prescriptions earlier than expected. Niraparib, which will be sold under the brand name Zejula, notched FDA approval on Monday, more than three months ahead of its June 30 decision date. The early approval setsTesaro up for a fierce battle for market share withAstraZeneca (NYSE:AZN)and Clovis Oncology (NASDAQ:CLVS), both of which market drugs that work similarly to Zejula.

stock market: China Advanced Construction Materials Group, Inc.(CADC)

Advisors’ Opinion:

  • [By Lisa Levin]

    China Advanced Constructn Mtrls Grp Inc (NASDAQ: CADC) shares shot up 225 percent to $7.15 after gaining 2.33 percent on Wednesday.

    Shares of Smart Global Holdings Inc (NASDAQ: SGH) got a boost, shooting up 29 percent to $36.98 after the company issued strong guidance. The company updated Q1 guidance, raising adjusted EPS from 79 cents-83 cents to 90 cents-93 cents. Sales guidance was raised from $225 million-$240 million to $250 million-$260 million.

stock market: Intrepid Potash, Inc(IPI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Wednesday afternoon, basic materials shares gained by 1.74 percent. Meanwhile, top gainers in the sector included Intrepid Potash, Inc. (NYSE: IPI), and L.B. Foster Co (NASDAQ: FSTR).

  • [By Lisa Levin]

    Monday afternoon, the basic materials shares surged 0.57 percent. Meanwhile, top gainers in the sector included CF Industries Holdings, Inc. (NYSE: CF), up 7 percent, and Intrepid Potash, Inc. (NYSE: IPI), up 7 percent.

  • [By Lisa Levin]

    Friday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from Intrepid Potash, Inc. (NYSE: IPI) and L.B. Foster Co (NASDAQ: FSTR).